| Age (y.o.) | 69 (39–87) |
| Gender (Male / Female) | 47 / 31 |
| Neoadjuvant therapy | 36 |
| Chemotherapy | 25 |
| Chemoradiotherapy | 11 |
| PTPE | 18 |
| Type of liver resectiona |
| No liver resection (PD, Extra bile duct resection) | 5 |
| S1,5,6,7,8 | 27 |
| S1,4,5,6,7,8 | 7 |
| S1,2,3,4 | 26 |
| S1,2,3,4,5,8 | 5 |
| Others | 8 |
| Histological type: G1 / G2 / G3 / others | 49 / 18 / 9 / 2 |
| TNM (UICC 8th) |
| pT: T0 / T1 / T2 / T3 / T4 | 1 / 8 / 33 / 12 / 24 |
| pN: N0 / N1 or N2 | 40 / 38 |
| M1 (Intrahepatic / Extrahepatic) | 6 (3 / 3) |
| Residual tumor status: R0 / R1 / R2 | 53 / 14 / 11 |
| Postoperative hospital stay (median: days) | 45.5 (13–325) |
| Complication ≥ C-D grade III | 32 |
| Postoperative chemotherapy | 56 |
